Expression of interest (EOI) for the provision of SPAQ chemoprevention efficacy sample analysis
It is the intent of this EOI to secure competitive proposals from qualified and experienced laboratory service providers for the analysis of samples to determine the chemoprevention efficacy of sulfadoxine-pyrimethamine (SPAQ) when used in seasonal malaria chemoprevention (SMC). The samples were collected or will be collected by Malaria Consortium and partners in countries where Malaria Consortium supports SMC. Attachments Bidder Response Document (BRD) – SPAQ Chemoprevention Efficacy Sample Analysis (68 kB)Expression of Interest (EOI) – SPAQ Chemoprevention Efficacy Sample Analysis…




